Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 1, 2006, Pages 1-4

  Vijverman, A ^a   Piront, P ^a   Belaiche, J ^a   Louis, Edouard ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anemia; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; FERRITIN; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; IRON; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; TIOGUANINE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BELGIUM; COHORT ANALYSIS; CROHN DISEASE; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; ENTERITIS; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MEGALOBLASTIC ANEMIA; PREVALENCE; REGISTER; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANEMIA, IRON-DEFICIENCY; BELGIUM; COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 33645696871     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. TRUELOVE S.C., WITTS L.J. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br. Med. J., 1955, 2: 1041-1047.
2. GASCHE C. Anemia in IBD: The Overlooked Villain. Inflammatory Bowel Disease, 2000, 6: 142-150.
3. MEANS R.T.J., KRANTZ S.B. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 1992, 80: 1639-47.
4. MEANS R.T., Jr. Advances in the anemia of chronic disease. Int. J. Hematol., 1999, 70: 7-12.
5. MAHIDA Y.R., WU K., JEWELL D.P. Enhance production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis or crohn's disease. Gut, 1989, 30: 835-838.
6. MAC DONALD T.T., HUTCHINGS P., CHOY M.Y., MURCH S., COOKE A. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed humane intestine. Clin. Exp. Immunol., 1990, 81: 301-305.
7. FANQUIN W.C., SCHNEIDER T.J., GOLDBERG M.A. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood, 1992, 79: 1987-1994.
8. JELKMANN W., FANDREY J., FREDE S., PAGEL H. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann. N.Y. Acad. Sci., 1994, 718: 300-309.
9. GASCHE C., DEJACO C., REINISCH W., TILLINGER W., WALDHOER T., FUEGER G., LOCHS H., GANGL A. Sequential Treatment of Anemia in Ulcerative Colitis with Intraveinous iron and Erythropoietin. Digestion, 1999, 60: 262-267.
10. GASCHE C., WALDHOER T., FEICHTENSCHALGR T., MALE C., MAYER A., MITTERMAIER C., PETRISCH W. Prediction of Response to Iron Sucrose in Inflammatory Bowel Disease-Associated Anemia. Am. J. Gastroenterol., 2001, 96: 2382-2387.
11. GASCHE C., REINISCH W., LOCHS H., PARDAEI B., BAKOS S., WYATT J., FUEGER J.F., GANGL A. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig. Dis. Sci., 1994, 39: 1930-1934.
12. THOMSON A.B.R., BRUST R., ALI M.A.N., MANT M.J., VALBERG L.S. Iron deficiency in inflammatory bowel disease. Am. J. Dig. Dis., 1978, 23: 705-709.
13. HORINA H.J., PETRITSCH W., SCHMID C.R., REICHT G., WENTZL H., SILLY H., KREJS G.J. Treatment of Anemia in Inflammatory bowel disease with Recombinant Human Erythropoietin: results in three patients. Gastroenterology, 1993, 104: 1828-31.
14. ESCHBACH J.W., ADAMSON J.W. Guidelines for recombinant human erythropoietin therapy. Am. J. Kidney Dis., 1989, 14 (Suppl 1): 2-8.
15. SCHREIBER S., WEDEL S. Diagnosis and treatment of anemia in inflammatory bowel diseases. Inflammatory bowel diseases. 1997, 3: 204-216.
16. GASCHE C., DEJACO C., WALDHOER T., REINISCH W., FUEGER G.F., GANGL A., LOCHS H. Intraveinous iron and Erythropoietin for Anemia associated with Crohn's disease. Ann. Intern. Med., 1997, 126: 782-787.
17. MAC DOUGALL I.C. Quality of life and anemia: the nephrology experience. Semin. Oncol., 1998, 25 (3 suppl7): 39-42.
18. GASCHE C., SCHOLMERICH J., BRYNSKOV J., D'HAENS G., HANAUER S.B., IRVINE E.J., JEWELL D.P., RACHMILEWITZ D., SACHAR D.B., SANDBORN W.J., SUTHERLAND L.R. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology. Vienna, 1998. Inflamm. Bowel Dis., 2000, 6: 8-15.
19. D'HAENS G., GEBOES K., RUTGEERTS P. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest. Endosc., 1999, 50: 667-71.
20. RUTGEERTS P., FEAGAN B.G., LICHTENSTEIN G.R., MAYER L.F. SCHREIBER S., COLOMBEL J.F. RACHMILEWITZ D., WOLF D.C., OLSON A., BAO W., HANAUER S.B. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology, 2004, 126: 402-13.